Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-04

Clinical Trial Update: Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial evaluating the safety and efficacy of DIT309 in advanced bone and soft tissue sarcomas, with the study status not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIT309

Snippet

Sponsor: Tcelltech Inc. | Conditions: Osteosarcoma, Soft Tissue Sarcoma | Phase 1 | Status: NOT_YET_RECRUITING